Biosimilars Conference 2015

This conference discusses biosimilars in the EU and internationally, with a focus on both regulatory and scientific challenges as well as market access and experiences.

Back to Agenda

Session 5 Users’ Experiences and Perspectives Regarding Biosimilars and Considerations on National Policy Developments

Session Chair(s)

Sabine Atzor, MPHARM, RPH

Head of EU Regulatory Policies, F. Hoffmann-La Roche Ltd, Switzerland

Suzette Kox, MPHARM

Senior Director International-Biosimilars Medicines Group, Medicines for Europe, Belgium

The session will continue by giving floor to health care professionals and patients and their points of view on the policy developments.

Speaker(s)

Carl-Erik Flodmark

Chief medical officer at Childhood , Childhood Obesity Unit Region Skane, Sweden

Thijs Giezen, PHARMD, PHD, MSC

, Medicines Evaluation Board, Netherlands

Biosimilars in Clinical Practice: the Perspective of the Hospital Pharmacist

Marco Greco, PHD

President , European Patients' Forum, Belgium

Patients' perspectives

Margaret Dolan

Regional Pharmacy Procurement Specialist, NHS Commercial Solutions, United Kingdom

Payer's perspective

Have an account?